Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erlotinib plus capecitabine as first-line treatment for older Chinese patients with advanced adenocarcinoma of the lung (C-TONG0807): an open-label, single arm, multicenter phase II study.
Zhao HY, Chen GY, Huang Y, Li XL, Feng JF, Shi MQ, Cheng Y, Ma LX, Zhang YP, Gu CP, Song XQ, Zhou D, Zhang L. Zhao HY, et al. Among authors: zhou d. Medicine (Baltimore). 2015 Jan;94(2):e249. doi: 10.1097/MD.0000000000000249. Medicine (Baltimore). 2015. PMID: 25590835 Free PMC article. Clinical Trial.
In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
Huang S, Zhou D, Li YX, Ming ZY, Li KZ, Wu GB, Chen C, Zhao YN. Huang S, et al. Among authors: zhou d. J Cell Physiol. 2019 Apr;234(4):3500-3514. doi: 10.1002/jcp.26863. Epub 2018 Oct 28. J Cell Physiol. 2019. Retraction in: J Cell Physiol. 2022 Mar;237(3):2000. doi: 10.1002/jcp.30512 PMID: 30370582 Retracted.
Corrigendum to "HIF-2α 1 inhibition disrupts leukemia stem cell metabolism and impairs vascular microenvironment to enhance chronic myeloid leukemia treatment" [Cancer lett. 597 (2024) 217060].
Wang J, Ma W, Huang J, Qiu G, Zhang T, Wei Q, He C, Zhou D, Zhao M, Chen C, Xu X. Wang J, et al. Among authors: zhou d. Cancer Lett. 2024 Dec 31:217435. doi: 10.1016/j.canlet.2024.217435. Online ahead of print. Cancer Lett. 2024. PMID: 39743443 No abstract available.
Corrigendum to <Disruption of the EGFR-SQSTM1 interaction by a stapled peptide suppresses lung cancer via activating autophagy and inhibiting EGFR signaling> <[ Cancer Letters 474 (2020) 23-35]>
Yu JJ, Zhou DD, Cui B, Zhang C, Tan FW, Chang S, Li K, Lv XX, Zhang XW, Shang S, Xiang YJ, Chen F, Yu JM, Liu SS, Wang F, Hu ZW, Hua F. Yu JJ, et al. Among authors: zhou dd. Cancer Lett. 2024 Dec 30:217434. doi: 10.1016/j.canlet.2024.217434. Online ahead of print. Cancer Lett. 2024. PMID: 39742989 No abstract available.
13,293 results
You have reached the last available page of results. Please see the User Guide for more information.